期刊文献+

涎腺粘液表皮样癌中Caveolin-1、PCNA的表达及意义 被引量:4

Expression and Significance of Caveolin-1 and PCNA in Mucoepidermoid Carcinoma of Salivary Glands
下载PDF
导出
摘要 目的:研究Caveolin-1、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)在涎腺粘液表皮样癌中的表达,分析二者的关系及其与肿瘤生物学行为间的关系。方法:采用SP免疫组化技术检测75例涎腺粘液表皮样癌标本及20例正常涎腺组织中Caveolin-1、PCNA的表达,并行统计学分析。结果:Caveolin-1在20例正常涎腺组织中均呈阳性表达。Caveolin-1表达下调与病程短、病理级别及临床分期的增高有关,短病程组和长病程组间(42.1%vs 67.6%)、低分化和高分化组间(38.5%vs 63.3%)、Ⅲ+Ⅳ期和Ⅰ+Ⅱ期组间(33.3%vs 64.7%)比较差异有统计学意义(P<0.05)。PCNA随着病理级别和临床分期的增高阳性表达率升高,低分化和高分化组间(33.38±11.98vs 20.12±10.13)、Ⅲ+Ⅳ期和Ⅰ+Ⅱ期组间(29.45±12.89vs 22.49±11.73)比较差异有统计学意义(P<0.05)。Caveolin-1与PCNA的表达呈负相关(rs=-0.28,P=0.017)。Caveolin-1表达降低及PCNA表达增高与肿瘤复发显著相关(P<0.05)。结论:Caveolin-1的表达对粘液表皮样癌细胞增殖起抑制作用,Caveolin-1是影响粘液表皮样癌发生发展的重要因素之一。 Objective: To investigate the expression and significance of caveolin- and proliferating cell nuclear antigen (PCNA) in mucoepidermoid carcinoma (MEC) of salivary glands. Methods: The expression of caveolin-1 and PCNA in MEC tissues (75 cases) and normal salivary glands tissues (20 cases, control group) were detected by immunohistochemical SP assay. Results.Caveolin-1 expression was presented in all normal salivary gland sam- pies. Reduced caveolin-1 expression was associated with shorter duration of tumor(shorter group vs longer group = 42.1% vs 67.6 %), higher grade malignance (high-grade vs lowgrade = 38. 5 % vs 63.3 %) and advanced clinical stage(Ⅲ+vs I +Ⅱ=29. 454±12.89 vs 22.49±11.73) (P〈0.05). There were significant differences in the expression of PCNA between high--grade MEC and low--grade MEC (33. 384-11.98 vs 20. 124-10.13) Ⅲ+ IVstages and I 4Ⅱtages (29.45+12.89 vs 22. 494-11.73) (P〈0.05). The expression of caveolin-- 1 was nega- tively related with the expression of PCNA (rs= -.28, P = 0. 017). Reduced caveolin-1 expression and increased PCNA expression were positively correlated with unfavorable outcome. Conclusion.. The currant data indicated a re- duction in caveolin- expression in MEC of salivary glands, which inversely correlated with patients" outcome and tumor cell proliferation, suggesting its role as a tumor supressor in MEC of salivary glands.
出处 《口腔医学研究》 CAS CSCD 北大核心 2011年第7期596-599,共4页 Journal of Oral Science Research
关键词 涎腺粘液表皮样癌 CAVEOLIN-1 增殖细胞核抗原 Salivary gland Mucoepidermoid carcinoma Caveolin--1 Proliferating cell nuclear antigen
  • 相关文献

参考文献18

  • 1Yin HF, Okada N, Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands [J] . Pathol Int, 2000, 50(8) : 603--609.
  • 2Goode RK, Auctair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria [J]. Cancer,1998, 82(7) : 1217--1224.
  • 3Razani B, Schlegel A, Liu J, Lisanti MP. Caveolin-1, a putative tumour suppressor gene [J]. Biochem Soc Trans, 2001, 29 : 494-499.
  • 4Seifert G. World Health Organization Classification of tumors: Histological typing of salivary gland tumors. 2nd ed. Berlin: Springerverlag, 1991 : 20.
  • 5Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcino-ma of ntraoral salivary glands; Evaluation and application of grading criteria in 143 cases [J]. Cancer, 1992, 69(8) : 2021 --2030.
  • 6Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepider- moid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading [J]. Am J Surg Pathol, 2001,25(7) : 835--845.
  • 7Sobin LH, Wittekind C. TNM classification of malignant tumors[M]. New York: John Wiley & Sons, 2002.
  • 8Park SS, Kim JE, Kim YA, et al. Caveolin--1 is down- regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast [J]. Histooathology, 2005, 47:625--630.
  • 9Mattern J, Koomagi R, Volm M. Association of vascular en- dothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epi- dermoid lung carcinoma [J], Br J Cancer, 1996, 73(7): 931--934.
  • 10Aulclair PL,Ellis GL. Mucoepidermoid carcinoma[A]. Ellis GL. Surgical Pathology of the Salivary Glands [M]. Philadelphia : W. B. Saunders, 1991,269.

二级参考文献18

  • 1Foote FW, Frazell EL. Tumors of the salivary glands [J]. Cancer, 1953, 6(6) : 1065-1133.
  • 2Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases [J]. Cancer, 1992, 69(8) : 2021 -2030.
  • 3Guzzo M, Andreola S, Sirizzotti G, et al. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan [J]. AnnSurgOncol, 2002, 9(7) : 688-695.
  • 4Yin HF, Okada N, Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands [J]. Pathol Int, 2000, 50(8) : 603-609.
  • 5Fujieda S, Sunaga H, Tsuzuki H, et al. Expression of plate let-derived endothelial cell growth factor in oral and oropha ryngeal carcinoma[J]. Clin Cancer Res, 1998, 4(7) :1583-1590.
  • 6Seifert G. World Health Organization Classification of tumors: Histological typing of salivary gland tumors [M]. Berlin: Springerverlag, 1991, 20- 21.
  • 7Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a elinieopathologie study of 80 patients with special reference to histological grading [J]. Am J Surg Pathol, 2001, 25(7) : 835-845.
  • 8Sobin LH, Wittekind CH. UICC:TNM classification of maglignant tumors [M]. New York:Wiley-liss, 1997, 17-46.
  • 9Mattern J, Koomagi R, Volta M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epi dermoid lung carcinoma[J]. Br J Cancer, 1996, 73(7) : 931 -934.
  • 10Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, et al. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptoticindex[J]. Pathol Oncol Res, 2001, 7(2) : 129- 134.

共引文献3

同被引文献27

  • 1Senetta R, Stella G, Pozzi E, et al. Caveolin-1 as a promoter of tumour spreading: when, how, where and why[J]. J Cell Mol Med, 2013,17(3):325-336.
  • 2Mo S], Yang SL, Cui Z. New glimpses of caveolin-1 functions in embryonic development and human diseasea[J]. Front Biol, 2011, 6 (5):367-376.
  • 3GoetzJG, Lajoie P, Wiseman SM, et al. Caveolin-1 in tumor pro? gression: the good, the bad and the ugly[J]. Cancer Metastasis Rev, 2008,27(4):715-735.
  • 4Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulumm.J Biol Chem, 2001, 276(6):4398-4408.
  • 5Sunaga N, Miyajima K, Suzuki M, et al. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer[J], Cancer Res, 2004, 64(12) :4277-4285.
  • 6Shi L, Chen XM, Wang L, et al. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical out? come[J], Cancer, 2007, 109(8):1523-1531.
  • 7Xia X, Ma Q. Li X, et al. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer[J]. BMC Cancer, 2011,11:399.
  • 8Saifo MS, Rempinski DJ, Rustum YM, et al. Targeting the oncogen? ic protein beta+carenin to enhance chemotherapy outcome against solid human cancers[J], Mol Cancer, 2010, 9:310.
  • 9Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-aldherin, increased transcription? al activity of beta-catenin, and enhanced tumor cell invasion[J]. Cancer Cell, 2003, 4(6):499-515.
  • 10Masuelli L, Budillon A, Marzocchella L, et al. Caveolin-1 overexpression is associated with simultaneous abnormal expression of the Ee-cadherin/o-B catenins complex and multiple erbb receptors and with lymph nodes metastasis in head and neck squamous cell carcinomasm.J Cell Physiol, 2012, 227(9):3344-3353.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部